Individuals frequently select this course of therapy for a variety of objectives, including skin attractiveness enhancement, immune system stimulation, or bodily detoxification
Mast cells appear to have GLP-1 receptors on their surface, and when GLP-1 or its analogues bind to those receptors, they may actually send a calming signal that reduces mast cell degranulation
Frequency depends on your goals and provider recommendations
Its ability to stimulate melanin production has made it a focal point of studies aimed at understanding skin cancer prevention and cosmetic applications
FDA-approved GLP-1 receptor agonists include semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)